节点文献
新型冠状病毒灭活疫苗接种者免疫效果的真实世界研究
A real-world study of the immunogenicity of inactivated SARS-CoV-2 vaccine
【摘要】 目的 研究完成3剂次新型冠状病毒灭活疫苗(简称新冠灭活疫苗)接种者的免疫效果及其相关影响因素。方法 选择2020年12月至2021年10月在南昌市第九医院完成3剂次新冠灭活疫苗接种者,于接种第1剂后3周,第2剂后4周、16周、32周,和第3剂后4周,分别抽取静脉血检测新型冠状病毒中和抗体、IgG和IgM抗体。结果 共纳入参与者874例,男316例,女558例。第1剂后3周,第2剂后4周、16周、32周,第3剂后4周中和抗体阳性率分别为26.2%、86.6%、74.2%、78.2%、98.1%;IgG抗体阳性率分别为25.1%、93.2%、59.3%、45.7%、96.8%。中和抗体定量及IgG抗体定量在第2剂后4周、16周、32周及第3剂后4周均明显高于第1剂后3周(P<0.0001);第2剂后16周、32周均明显低于第2剂后4周(P <0.0001);第3剂后4周均明显高于第1剂后4周(P <0.0001)。结论 接种2剂新冠灭活疫苗可以产生较多数量的中和抗体和IgG抗体以发挥免疫效果,增加第3剂加强针后可以明显升高二者峰值。
【Abstract】 Objective To study the immunogenicity and related factors of the 3 doses inactivated SARS-CoV-2 vaccine. Method People who received 3 doses of inactivated SARS-CoV-2 vaccine in Nanchang Ninth Hospital from December 2020 to October 2021 were selected, At 3 weeks after the first dose,4 weeks,16 weeks and 32 weeks after the second dose, and 4 weeks after the third dose, the blood neutralizing antibody, IgG and IgM antibody were detected respectively. Result A total of 874 participants were enrolled, including 316 males and 558 females. The positive rates of neutralizing antibody were 26.2%, 86.6%, 74.2%, 78.2% and 98.1% respectively at 3 weeks after the first dose, 4 weeks, 16 weeks, 32 weeks after the second dose and 4 weeks after the third dose;The positive rates of IgG antibody were 25.1%, 93.2%, 59.3%, 45.7% and 96.8% respectively. The quantitation of neutralizing antibody and IgG antibody at 4,16,32 weeks after the second dose and 4 weeks after the third dose were significantly higher than those at 3 weeks after the first dose(P<0.0001); 16,32 weeks after the second dose were significantly lower than 4 weeks after the second dose(P<0.0001); 4 weeks after the third dose were significantly higher than 4 weeks after the second dose(P<0.0001). Conclusion Two doses of the inactivated SARS-CoV-2 vaccine can produce a large number of neutralizing and IgG antibodies to play the immune effect, and the addition of the third dose of booster can significantly increase the peak value of both.
【Key words】 Severe acute respiratory syndrome coronavirus 2; Vaccine; Neutralizing antibody; Immuno globulin G; Immunogenicity; Real-world study;
- 【文献出处】 新发传染病电子杂志 ,Electronic Journal of Emerging Infectious Diseases , 编辑部邮箱 ,2023年03期
- 【分类号】R186
- 【下载频次】29